Medscape

Letrozole-Based Regimen Effective, Well Tolerated for Endometriosis Treatment

Feb. 13, 2004 — The combination of the aromatase inhibitor letrozole and the progestin norethindrone acetate is effective and well tolerated for women poorly responsive to medical and surgical therapy ...
Nature

Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer

To assess whether the combination of letrozole, metronomic cyclophosphamide and sorafenib (LCS) is well tolerated and shows activity in primary breast cancer (BC). Thirteen oestrogen receptor-positive ...
Healio

Abemaciclib plus letrozole effective in treating recurrent ER-positive endometrial cancer

Please provide your email address to receive an email when new articles are posted on . Results from a phase 2 study showed that abemaciclib in combination with letrozole shrunk or stabilized tumors ...
ascopubs.org

Randomized Phase II Trial of Letrozole and Letrozole Plus Low-Dose Metronomic Oral Cyclophosphamide As Primary Systemic Treatment in Elderly Breast Cancer Patients

Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study to NCIC CTG MA.17 One hundred ...
ascopubs.org

Stand Up to Cancer Phase Ib Study of Pan-Phosphoinositide-3-Kinase Inhibitor Buparlisib With Letrozole in Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 ...

Stereotactic Body Radiation Therapy Versus Intensity-Modulated Radiation Therapy for Prostate Cancer: Comparison of Toxicity Patients received letrozole and buparlisib in two different administration ...
FiercePharma

Chugai and Novartis Pharma to Terminate Co-Marketing Agreement of Aromatase Inhibitor "Femara® Tablets 2.5 mg," a Treatment for Breast Cancer after Menopause

TOKYO, January 6, 2016 - Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) announced today that Chugai and Novartis Pharma K.K. have agreed to terminate the agreement regarding co-marketing of aromatase ...
Healio

Letrozole–lapatinib combination did not improve outcomes in HR-positive, HER-2–negative breast cancer

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio The addition of lapatinib to letrozole ...